MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: A double-blind, randomized, placebo-controlled clinical trial

European Respiratory Journal

Volumn 9, Issue 7, 1996, Pages 1482-1486

  Luisetti, M ^a   Sturani, C ^b   Sella, D ^b   Madonini, E ^c   Galavotti, V ^b   Bruno, G ^d   Peona, V ^a   Kucich, U ^e   Dagnino, G ^d   Rosenbloom, J ^e   Starcher, B ^f   Grassi, C ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Divisione di Pneumologia   (Italy)

^c Medea Research ^*  (Italy)

^d Medea Research   (Italy)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

chronic bronchitis; elastin; plasma elastin derived peptides; pulmonary emphysema; urinary desmosine

Indexed keywords

ELASTASE INHIBITOR; MIDESTEINE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; DESMOSINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELASTIN; FEMALE; HUMANS; LEUKOCYTE ELASTASE; LUNG DISEASES, OBSTRUCTIVE; MALE; PROTEASE INHIBITORS; THIOPHENES; TIME FACTORS;

EID: 8944254696     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09071482     Document Type: Article

References (27)

1. Potempa J, Korzus E, Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 1994; 269: 15957-15960.
2. Janoff A. Elastases and emphysema: current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 1985; 132: 417-433.
3. 1-antichymotrypsin. J Biol Chem 1980; 255: 3931-3934.
4. 1-proteinase inhibitor. Am J Physiol 1994: 266 (Lung Cell Mol Physiol 10): L593-L611.
5. Stockley RA, Burnett D. Bronchoalveolar lavage and the study of proteinases and antiproteinases in the pathogenesis of chronic obstructive lung disease. Monaldi Arch Chest Dis 1993; 48: 245-253.
6. Snider GL, Stone PJ, Lucey EC. The specific treatment of emphysema. Eur Respir J 1990; 3 (suppl. 9): 23s-28s.
7. Eriksson S. The potential role of elastase inhibitors in emhysema treatment. Eur Respir J 1991; 4: 1041-1043.
8. Powers JC, Bengali ZH. Elastase inhibitors for treatment of emphysema: approaches to synthesis and biological evaluation. Am Rev Respir Dis 1986; 134: 1097-1100.
9. Baici A, Pelloso R, Horler D. The kinetic mechanism of inhibition of human leukocyte elastase by MR889, a new cyclic thiolic compound. Biochem Pharmacol 1990; 39: 919-924.
10. Luisetti M, Piccioni PD, Donnini M, Peona V, Pozzi E, Grassi C. Studies of MR889, a new synthetic proteinase inhibitor. Biochem Biophys Res Commun 1989; 165: 568-573.
11. Powers JC, Kam CM, Hori H, Oleksyszyn J, Meyer EF Jr. Synthetic mechanism-based and transition-state inhibitors for human neutrophil elastase. In: Grassi C, Travis J, Casali L, Luisetti M, eds. Biochemistry of Pulmonary Emphysema. London, Springer-Verlag, 1992: 123-141.
12. Rizzi M, Casale E, Ascenzi P, et al. Crystal structure and NMR investigation of the serine proteinase inhibitor MR889, a cyclic thiolic compound. J Chem Soc Perkin Trans 2 1993: 11; 2253-2256.
13. Rizzi M, Casale E, Coda A, et al. Serine proteinase inhibition by the cyclic thiolic compound YS3025: a crystallographic study. Biochem Int 1992; 28: 385-392.
14. Djinovic Carugo K, Rizzi M, Fasano M, et al. Inhibition of serine proteinases belonging to the chymotrypsin superfamily by the cyclic thiolic compound YS3025: a comparative crystallographic study. Biochem Biophys Res Commun 1993; 193: 32-39.
15. Anthonisen N. Design of a clinical trial to test a treatment of the underlying cause of emphysema. Ann NY Acad Sci 1991; 624S: 31-34.
16. American Thoracic Society. Standards for diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
17. King GS, Mohan VS, Starcher BC. Radioimmunoassay for desmosine. Connect Tissue Res 1980; 7: 263-267.
18. Starcher B, Conrad M. A role for neutrophil elastase in the progression of solar elastosis. Connect Tissue Res 1995; 31: 133-140.
19. Cohen AB, Girard W, McLarty J, et al. A controlled trial of colchicine to reduce the elastase load in the lungs of cigarette smokers with chronic obstructive pulmonary disease. Am Rev Respir Dis 1990; 142: 63-72.
20. Kucich U, Christner P, Lippmann M, et al. Utilization of a peroxidase antiperoxidase complex in an enzyme-linked immunosorbent assay of elastin-derived peptides in human plasma. Am Rev Respir Dis 1985; 131: 709-713.
21. Snider GL, Stone PJ. Lucey EC. Development and evaluation of antiproteases as drugs for preventing emphysema. In: Grassi C, Travis J, Casali L, Luisetti M, eds. Biochemistry of Pulmonary Emphysema. London, Springer-Verlag, 1992: pp. 144-158.
22. Glass M. The feasibility of an outcome trial in the preventive therapy of emphysema. Ann NY Acad Sci 1991; 624: 195-208.
23. Cohen AB. Clinical trials to treat the underlying cause of emphsyema. Monaldi Arch Chest Dis 1994; 49: 95-97.
24. Rosenbloom J. Biochemical/immunological markers of emphysema. Ann NYAcad Sci 1991; 624s: 7-12.
25. Cohen AB, Girard W, Mclarty J, et al. A controlled trial of colchicine to reduce the elastase load in the lungs of ex-cigarette smokers with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143: 1038-1043.
26. Starcher B, Green M, Scott M. Urinary desmosine as an indicator of acute pulmonary disease. Respiration 1995; 62: 252-257.
27. 1-antitrypsin deficient humans. Respiration 1995; 62: 76-79.